CELG News 96.21 09/25/2014 04:35:58 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 96.21 $CELG

'Fast Money' Recap: What Market? The Focus Remains on Apple
at The Street - 35 mins ago
The trading panel discussed how low the market can go and whether biotech stocks can continue to move higher.

Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market
at The Street - Wed Sep 24, 7:24PM CDT
Investors always need to be prepared for when common sense returns to the market, Cramer says.

Final Glance: Biotechnology companies
AP - Wed Sep 24, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:

Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 4:30PM CDT
Celgene's (CELG) Otezla gained FDA approval for plaque psoriasis.

Watch for Celgene to Potentially Pullback After Gaining 3.32% Yesterday
Comtex SmarTrend(R) - Wed Sep 24, 3:44PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $93.88 to a high of $96.30. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $94.96 on volume of 5.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 3.32% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Sep 24, 3:44PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $93.88 to a high of $96.30. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $94.96 on volume of 5.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Stocks Up In Afternoon; Hasbro Jumps On Disney Deal
at Investor's Business Daily - Wed Sep 24, 2:05PM CDT
The major averages were hitting fresh intraday highs in late afternoon trading Wednesday, spurred by dovish comments from a top Federal Reserve policymaker. The Nasdaq and the Dow Jones industrial average each added 0.9%, while the S&P 500 picked up...

Midday Glance: Biotechnology companies
AP - Wed Sep 24, 12:21PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:

Stocks Rally To Session Highs; Celgene Leads Biotech Rally
at Investor's Business Daily - Wed Sep 24, 10:49AM CDT
Major averages rallied off lows and were near session highs more than two hours into Wednesday's session. The Nasdaq led the way, up 0.6%, after touching its 50-day moving average. The Dow Jones industrial average and S&P 500 added 0.5% each. NYSE...

Jim Cramer's Mad Dash: Celgene and Morgan Stanley Still Have Upside
at The Street - Wed Sep 24, 9:58AM CDT
TheStreet's Jim Cramer says he still likes Celgene and Morgan Stanley near current levels since both stocks still have upside.

Early Glance: Biotechnology companies
AP - Wed Sep 24, 9:33AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Watch for Shares of Celgene (CELG) to Approach Resistance at $94.76
Comtex SmarTrend(R) - Wed Sep 24, 8:58AM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $92.78 today and has reached the first level of resistance at $93.94. Should the shares continue to rise, the resistance pivots of $94.76 and $96.74 will be of interest.

Market Maker Surveillance Report. EBAY, JRJC, MU, AAPL, RFMD, CELG, Highest Net Buy Volume With Lowest Price Friction For Tuesday, September 23rd 2014
M2 - Wed Sep 24, 3:41AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4582 companies with "abnormal" market making, 1424 companies with positive Friction Factors and 3854 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Tuesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. eBay Inc (NASDAQ:EBAY), China Finance Online Co Ltd (NASDAQ:JRJC), Micron Technology Inc (NASDAQ:MU), Apple Inc (NASDAQ:AAPL), RF MICRO DEVICES, INC. (NASDAQ:RFMD), Celgene Corp (NASDAQ:CELG). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Celgene's
at Investor's Business Daily - Tue Sep 23, 5:45PM CDT
Celgene's (CELG) Otezla received FDA approval for the oral treatment of psoriasis, which causes red, scaly patches on the skin and affects 7.5 mil Americans. It's typically treated with injections, like AbbVie's (ABBV) Humira. Celgene shares rose 1%...

Oral OTEZLA(R) (apremilast) Approved by the U.S. Food and Drug Administration for the Treatment of Patients with Moderate to Severe Plaque Psoriasis
Business Wire - Tue Sep 23, 2:18PM CDT
--OTEZLA demonstrated a consistent safety and tolerability profile across clinical trials

Zeldes Haeggquist & Eck, LLP Announces Investigation of Celgene, Inc.
Business Wire - Mon Sep 22, 8:01AM CDT
Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into possible breaches of fiduciary duty and other violations of law by certain officers and directors at Celgene, Inc. ("Celgene" or the "Company" .

IBD 50 Stocks Setting Up, Including These 5 Medicals
at Investor's Business Daily - Fri Sep 19, 6:36PM CDT
Recent volatility in the stock market, including an outlook shift to uptrend under pressure and back to a confirmed uptrend, may have rattled investors' nerves. But it's also helped set up new potential entries as some leading stocks slipped into buy...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Carnival Maps a Longer, Broader Bet on Cruise Demand

Updated Category News Views 36

A cruise operator does not order ships for 2035 because it is feeling timid. Carnival is laying out a long runway of hardware, private-destination capacity and onboard-to-onshore spending hooks, all aimed at keeping guests inside its ecosystem longer. For NYSE:CCL, this is not a next-quarter story. It is a very public statement that management sees enduring appetite for...

Continue Reading
Dar Global’s $700M Qatar Bet Leans on Trump Branding

Updated Category News Views 29

Luxury property launches rarely arrive quietly, and this one came wrapped in Palm Beach ceremony, championship golf and a very loud brand name. Dar Global has formally introduced Trump International Simaisma, Qatar, a QAR 2.5 billion development—about $700 million—alongside The Trump Organization. That is a meaningful chunk of real estate ambition, not a little side...

Continue Reading
Mace Consult Bets on Sawaya for Americas Expansion

Updated Category News Views 120

Concrete, tunnel bores, and data-center campuses rarely wait politely for a leadership transition. Mace Consult has named Mario Sawaya president of its Americas business, and the hire reads less like ceremonial executive shuffling than a deliberate move toward the thickest part of the capital-spending map. Sawaya brings more than 20 years of experience leading...

Continue Reading
Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 166

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading
AI Forces Learning Teams to Redefine Their Core Job

Updated Category News Views 89

Training Departments Are Not Sitting Still Corporate learning has spent years being treated like the office instruction manual, and AI is making that old arrangement look awfully flimsy. RedThread Research's November 19, 2026 study lands on a point that ought to make senior management pay attention: learning and development leaders are not merely waiting around to be...

Continue Reading
IQSTEL’s 2027 Plan Has Scale but Still Needs Proof

Updated Category News Views 46

A $313 million nine-month revenue figure gets attention, yet this story is really about whether IQSTEL can finally turn a big telecom pipe into money that sticks. The company grew consolidated revenue 34.5% year over year through September 30, 2026, and third-quarter revenue hit $106.0 million, its second straight quarter above $100 million. That is real operating scale,...

Continue Reading
Neusoft's OneCoreGo Win Puts Auto Software in Focus

Updated Category News Views 101

A Dashboard Award Is Not Just About Pretty Pixels Crystal-like graphics and augmented-reality pathways may sound like the sort of thing a marketing department dreams up after too much coffee, but the more interesting bit in Neusoft's latest news is the machinery underneath. OneCoreGo 7.0 has received the Red Dot Design Award after taking a German iF Design Award earlier...

Continue Reading
JDEnergy's RE+ Push Meets a Grid Hungry for Storage

Updated Category News Views 64

Certification Is Useful, Not a Victory Lap A battery box earning a safety certificate is not usually thrilling stuff, but the timing matters here. On Nov. 19, 2026, JDEnergy laid out its North American storage pitch at RE+ in Las Vegas while electricity demand is getting shoved higher by industrial buildout and AI data centers. Add more variable renewable generation to an...

Continue Reading
Elanco’s $600 Million Buyback Signals a New Chapter

Updated Category News Views 93

Debt coming down and cash coming in finally gave Elanco room to breathe. On Nov. 19, 2026, the animal-health company authorized its first-ever share repurchase program, allowing up to $600 million of common-stock purchases. For NYSE: ELAN, this is more than a flashy capital-return headline. It marks a shift from the ugly but necessary job of balance-sheet repair toward a...

Continue Reading
Five SEAL Medal of Honor Signatures, One Charity Lot

Updated Category News Views 74

A single rifle can carry a staggering amount of meaning when the names on it belong to all five living U.S. Navy SEAL Medal of Honor recipients. Rock Island Auction Company plans to offer that one-of-a-kind custom precision rifle during its December 4–6, 2026 Premier Firearms Auction, and the financial arrangement is unusually clean: 100% of proceeds are slated for the...

Continue Reading

Top 5 Most Recently Viewed Articles

Xometry Prepares for Financial Report Ahead of Market Opening

Updated Category News Views 175

Xometry Financial Results Announcement Overview Xometry, Inc. (NASDAQ: XMTR), recognized as a leading AI-powered marketplace for manufacturing services, is gearing up to announce its fourth quarter and full year 2024 financial results. The report is expected to be made available before trading opens on the market. This announcement represents a significant opportunity for...

Continue Reading
Warren Buffett's Surprising Bet on the RV Industry Pays Off

Updated Category News Views 1216

Warren Buffett's Unconventional Investment Journey Warren Buffett, known for his wisdom in investing, made a surprising decision that changed the game for Berkshire Hathaway Inc. He chose to invest in Forest River, an RV manufacturer, despite having little knowledge of the industry. This significant move, spearheaded by the late founder Pete Liegl, proved to be highly...

Continue Reading
BizClik Media Unveils September Editions of Key Industry Magazines

Updated Category News Views 201

BizClik Media Unveils September Editions of Key Publications This September, the latest editions of Supply Chain Digital, Procurement Magazine, and Manufacturing Digital have been published, featuring engaging interviews with industry leaders and experts from prominent companies. Spotlighting Industry Leaders This month's issues highlight a variety of thought-provoking...

Continue Reading
Ascletis Unveils Breakthrough Findings for ASC30 Injection

Updated Category News Views 210

Exciting Developments in Obesity Treatment with ASC30 In the realm of obesity management, Ascletis Pharma Inc. has made significant strides with their investigational drug ASC30, a promising GLP-1 receptor (GLP-1R) agonist designed for both oral and subcutaneous use. Preliminary results from their Phase Ib trial conducted in the U.S. indicate a fascinating half-life of 36...

Continue Reading
CBIZ Welcomes Kathy Raffa to Its Board of Directors

Updated Category News Views 204

CBIZ Strengthens Board with New Appointment CBIZ, Inc. (NYSE: CBZ), a prominent national professional services advisor, has recently announced the addition of Kathy Raffa to its Board of Directors. This strategic appointment, effective January 15, 2025, follows CBIZ's recent acquisition of the non-attest assets of Marcum. This move is seen as a testament to the...

Continue Reading